Status:
COMPLETED
Evaluation of PENG Block in Terms of Block Time and Postoperative Pain
Lead Sponsor:
Diskapi Yildirim Beyazit Education and Research Hospital
Conditions:
Postoperative Pain
Eligibility:
All Genders
40-85 years
Phase:
NA
Brief Summary
Hip fracture is a common orthopedic emergency in the elderly and causes significant morbidity and is associated with mortality. In most patients, surgical reduction and fixation is the definitive trea...
Detailed Description
Patients in the ASA 1-3 group who had hip surgery with PENG block for any reason will be included in the study. Approximately 60 patients will participate in the study, the number will be finalized as...
Eligibility Criteria
Inclusion
- \- Patients who have undergone hip surgery with PENG block for any reason
Exclusion
- chronic opioid users
- cognitive disorders
- written consent form haven't get
- history of relevant drug allergy
- infection of the skin at the site of needle puncture area
- coagulopathy
Key Trial Info
Start Date :
October 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 10 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06132308
Start Date
October 15 2023
End Date
August 10 2024
Last Update
November 5 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology and Reanimation, University of Health Sciences, Diskapi Yıldırım Beyazit Training and Research Hospital
Ankara, Turkey (Türkiye), 06450
2
university of health siences diskapi yildirim beyazit T&R hospital
Ankara, Turkey (Türkiye)